3.0.0 1092 2025-12-05T08:42:14Z 2025-12-05T08:42:14Z House H HR 2023-02-17 118 https://www.congress.gov/bill/118th-congress/house-bill/1092 <pre>[Congressional Record Volume 169, Number 33 (Friday, February 17, 2023)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Ms. MATSUI:H.R. 1092.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the United States ConstitutionThe single subject of this legislation is:To strengthen the use of patient-experience data within thebenefit-risk framework for approval of new drugs.[Page H856]</pre> hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2023-02-24T16:33:22Z Referred To 2023-02-17T15:07:00Z 118 526 S 2023-02-16 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Identical bill CRS 2023-02-24 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2023-02-17 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2023-02-17 Introduced in House IntroReferral Intro-H 9 Library of Congress 2023-02-17 Introduced in House IntroReferral 1000 9 Library of Congress M001163 Rep. Matsui, Doris O. [D-CA-7] Doris Matsui D CA O. 7 N W000815 Rep. Wenstrup, Brad R. [R-OH-2] Brad Wenstrup R OH R. 2 2023-02-17 True B001257 Rep. Bilirakis, Gus M. [R-FL-12] Gus Bilirakis R FL M. 12 2023-03-21 False P000597 Rep. Pingree, Chellie [D-ME-1] Chellie Pingree D ME 1 2023-04-10 False Y000067 Rep. Yakym, Rudy [R-IN-2] Rudy Yakym R IN 2 2023-04-10 False G000590 Rep. Green, Mark E. [R-TN-7] Mark Green R TN E. 7 2023-04-13 False R000305 Rep. Ross, Deborah K. [D-NC-2] Deborah Ross D NC K. 2 2023-04-18 False B001309 Rep. Burchett, Tim [R-TN-2] Tim Burchett R TN 2 2023-04-19 False G000592 Rep. Golden, Jared F. [D-ME-2] Jared Golden D ME F. 2 2023-05-02 False W000826 Rep. Wild, Susan [D-PA-7] Susan Wild D PA 7 2023-09-08 False B001298 Rep. Bacon, Don [R-NE-2] Don Bacon R NE 2 2023-09-08 False C001061 Rep. Cleaver, Emanuel [D-MO-5] Emanuel Cleaver D MO 5 2023-09-08 False C001097 Rep. Cárdenas, Tony [D-CA-29] Tony Cárdenas D CA 29 2023-09-26 False H001090 Rep. Harder, Josh [D-CA-9] Josh Harder D CA 9 2023-09-26 False F000466 Rep. Fitzpatrick, Brian K. [R-PA-1] Brian Fitzpatrick R PA K. 1 2023-09-26 False T000488 Rep. Thanedar, Shri [D-MI-13] Shri Thanedar D MI 13 2023-10-10 False H001038 Rep. Higgins, Brian [D-NY-26] Brian Higgins D NY 26 2023-10-10 False N000147 Del. Norton, Eleanor Holmes [D-DC-At Large] ELEANOR NORTON D DC HOLMES 0 2023-10-10 False P000616 Rep. Phillips, Dean [D-MN-3] Dean Phillips D MN 3 2023-10-12 False C001053 Rep. Cole, Tom [R-OK-4] Tom Cole R OK 4 2023-10-18 False G000583 Rep. Gottheimer, Josh [D-NJ-5] Josh Gottheimer D NJ 5 2023-10-30 False V000133 Rep. Van Drew, Jefferson [R-NJ-2] Jefferson Van Drew R NJ 2 2023-12-05 False G000582 Rescom. González-Colón, Jenniffer [R-PR-At Large] Jenniffer Gonzalez-Colon R PR 0 2023-12-22 False L000578 Rep. LaMalfa, Doug [R-CA-1] Doug LaMalfa R CA 1 2024-01-29 False L000599 Rep. Lawler, Michael [R-NY-17] Michael Lawler R NY 17 2024-03-07 False T000467 Rep. Thompson, Glenn [R-PA-15] Glenn Thompson R PA 15 2024-03-19 False J000307 Rep. James, John [R-MI-10] John James R MI 10 2024-03-19 False W000797 Rep. Wasserman Schultz, Debbie [D-FL-25] Debbie Wasserman Schultz D FL 25 2024-05-21 False T000469 Rep. Tonko, Paul [D-NY-20] Paul Tonko D NY 20 2024-05-22 False L000601 Rep. Landsman, Greg [D-OH-1] Greg Landsman D OH 1 2024-06-07 False B001306 Rep. Balderson, Troy [R-OH-12] Troy Balderson R OH 12 2024-06-26 False G000576 Rep. Grothman, Glenn [R-WI-6] Glenn Grothman R WI 6 2024-09-25 False Health Health 2023-03-15T20:15:17Z

00 2023-02-17 Introduced in House 2023-06-22T13:17:09Z <p><b>Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 or the BENEFIT Act of </b><b>2023</b></p> <p>This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.</p> <p>After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework. </p>

Display Title 45 2024-07-24T15:23:37Z Short Title(s) as Introduced 101 2024-05-24T13:42:10Z Introduced in House IH Short Title(s) as Introduced 101 2024-05-24T13:42:10Z Introduced in House IH Official Title as Introduced 6 2024-03-18T20:21:19Z Introduced in House IH Introduced in House 2023-02-17T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118hr1092ih/xml/BILLS-118hr1092ih.xml 2023-02-24 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.